Sex and sex steroid influences on dry eye syndrome

Dry Eye and Ocular Surface Disorders

Volumn , Issue , 2004, Pages 165-190

  Sullivan, David A ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77049103147     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (267)

1. Caffery BE, Richter D, Simpson T, Fonn D, Doughty M, Gordon K. CANDEES: the Canadian dry eye epidemiology study. Adv Exp Med Biol 1998; 438:805-806.
2. McCarty CA, Bansal AK, Livingston PM, Stanislavsky YL, Taylor HR. The epidemiology of dry eye in Melbourne, Australia. Ophthalmology 1998; 105:1114-1119.
3. PharMetrics/NDC Health Information Services. Prevalence and treatment of dry eye in a managed care population. Draft Report, 2000.
4. Schaumberg DA, Sullivan DA, Dana MR. Epidemiology of dry eye syndrome. Adv Exp Med Biol 2002; 506:989-998.
5. Albietz JM. Prevalence of dry eye subtypes in clinical optometry practice. Optom Vis Sci 2000; 77:357-363.
6. Versura P, Profazio V, Cellini M, Torreggiani A, Caramazza R. Eye discomfort and air pollution. Ophthalmologica 1999; 213:103-109.
7. Schaumberg DA, Sullivan DA, Buring JE, Dana MR. Prevalence of dry eye syndrome among US women. Am J Ophthalmol 2003, 136:318-326.
8. Caffery B, Richter D, Simpson T, Fonn D, Doughty M, Gordon K. The prevalence of dry eye in contact lens wearers: Part 2 of the Canadian Dry Eye Epidemiology Study (CANDEES). Invest Ophthalmol Vis Sci 1996; 37:S72.
9. Sullivan DA, Wickham LA, Krenzer KL, Rocha EM, Toda I. Aqueous tear deficiency in Sjögren’s syndrome: possible causes and potential treatment. In: Pleyer U, Hartmann C, Sterry W, eds. Oculodermal Diseases-Immunology of Bullous Oculo-Muco-Cutaneous Disorders. Buren, The Netherlands: Aeolus Press, 1997:95-152.
10. Toda I, Wickham LA, Sullivan DA. Gender and androgen treatment influences the expression of proto-oncogenes and apoptotic factors in lacrimal and salivary tissues of MRL/lpr mice. Clin Immunol Immunopathol 1998; 86:59-71.
11. Toda I, Sullivan BD, Wickham LA, Sullivan DA. Gender and androgen-related influence on the expression of proto-oncogene and apoptotic factor mRNAs in lacrimal glands of autoimmune and non-autoimmune mice. J Steroid Biochem Molec Biol 1999; 71:49-61.
12. Toda I, Sullivan BD, Rocha EM, Silveira LA, Wickham LA, Sullivan DA. Impact of gender on exocrine gland inflammation in mouse models of Sjögren’s syndrome. Exp Eye Res 1999; 69:355-366.
13. Rocha EM, Hirata AE, Carneiro EM, Saad MJ, Velloso LA. Impact of gender on insulin signaling pathway in lacrimal and salivary glands of rats. Endocrine 2002; 18:191-199.
14. Cavallero C. Relative effectiveness of various steroids in an androgen assay using the exorbital lacrimal gland of the castrated rat. Acta Endocrinol (Copenh) 1992; 55:119-130.
15. Gabe M. Conditionnement hormonal de la morphologie des glandes sus-parotidiennes chez le Rat albinos. C R Séanc Soc Biol 1955; 149:223-225.
16. Cornell-Bell AH, Sullivan DA, Allansmith MR. Gender-related differences in the morphology of the lacrimal gland. Invest Ophthalmol Vis Sci 1985; 26:1170-1175.
17. Cripps MM, Bromberg BB, Welch MH. Gender-dependent lacrimal protein secretion. Invest Ophthalmol Vis Sci Suppl 1986; 27:25.
18. Ducommun P, Ducommun S, Baquiche M. Comparaison entre l’action du 17-ethyl-19-nor-testosterone et du propionate de testosterone chez le rat adulte et immature. Acta Endocrinol 1959; 30:78-92.
19. Walker R. Age changes in the rat’s exorbital lacrimal gland. Anat Rec 1958; 132:49-69.
20. Luciano L. Die feinstruktur der tränendrüse der ratte und ihr geschlechtsdimorphismus. Z Zellforschung 1967; 76:1-20.
21. Paulini K, Beneke G, Kulka R. Age- and sex-dependent changes in glandular cells. I. Histologic and chemical investigations on the glandular lacrimalis, glandular intraorbitalis, and glandula orbitalis external of the rat. Gerontologia 1972; 18:131-146.
22. Paulini K, Mohr W, Beneke G, Kulka R. Age- and sex-dependent changes in glandular cells. II. Cytomorphometric and autoradiographic investigations on the glandular lacrimalis, glandular intraorbitalis, and glandula orbitalis external of the rat. Gerontologia 1972; 18:147-156.
23. Pangerl A, Pangerl B, Jones DJ, Reiter RJ. b-Adrenoreceptors in the extraorbital lacrimal gland of the syrian hamster. Characterization with [125I]-iodopindolol and evidence of sexual dimorphism. J Neural Transm 1989; 77:153-162.
24. Mhatre MC, van Jaarsveld AS, Reiter RJ. Melatonin in the lacrimal gland: first demonstration and experimental manipulation. Biochem Biophys Res Commun 1988; 153:1186-1192.
25. Sullivan DA, Hann LE, Yee L, Allansmith MR. Age- and gender-related influence on the lacrimal gland and tears. Acta Ophthalmol 1990; 68:188-194.
26. Shaw PH, Held WA, Hastie ND. The gene family for major urinary proteins: expression in several secretory tissues of the mouse. Cell 1983; 32:755-761.
27. Tier H. Über Zellteilung und Kernklassenbildung in der Glandula orbitalis externa der Ratte. Acta Path Microbiol Scand Suppl 1944; 50:1-185.
28. Sullivan DA, Allansmith MR. The effect of aging on the secretory immune system of the eye. Immunology 1988; 63:403-410.
29. Hann LE, Allansmith MR, Sullivan DA. Impact of aging and gender on the Ig-containing cell profile of the lacrimal gland. Acta Ophthalmol 1988; 66:87-92.
30. Hahn JD. Effect of cyproterone acetate on sexual dimorphism of the exorbital lacrimal gland in rats. J Endocrinol 1969; 45:421-425.
31. Baquiche M. Le dimorphisme sexuel de la glande de Loewenthal chez le rat albinos. Acta Anat 1959; 36:247-280.
32. Gao J, Lambert RW, Wickham LA, Banting G, Sullivan DA. Androgen control of secretory component mRNA levels in the rat lacrimal gland. J Steroid Biochem Molec Biol 1995; 52:239-249.
33. Lorber M, Vidic B. Weights and dimensions of 16 lacrimal glands from human cadavers. Invest Ophthalmol Vis Sci Suppl 1994; 35:1790.
34. Waterhouse JP. Focal adenitis in salivary and lacrimal glands. Proc R Soc Med 1963; 56:911-918.
35. Craig JP, Tomlinson A. Effect of age on tear osmolality. Optom Vis Sci 1995; 72:713-717.
36. Lauria A, Porcelli F. Leucine aminopeptidase (LAP) activity and sexual dimorphism in rat exorbital gland. Basic Appl Histochem 1979; 23:171-177.
37. Azzarolo AM, Mazaheri AH, Mircheff AK, Warren DW. Sex-dependent parameters related to electrolyte, water and glycoprotein secretion in rabbit lacrimal glands. Curr Eye Res 1993; 12:795-802.
38. Ranganathan V, De PK. Androgens and estrogens markedly inhibit expression of a 20-kDa major protein in hamster exorbital lacrimal gland. Biochem Biophys Res Commun 1995; 208:412-417.
39. Kenney MC, Brown DJ, Hamdi H. Proteinase activity in normal human tears: male-female dimorphism. Invest Ophthalmol Vis Sci 1995; 36:S4606.
40. Krawczuk-Hermanowiczowa O. Effects of sexual glands on the lacrimal gland. II. Changes in rat lacrimal glands after castration. Klin Oczna 1983; 85:15-17.
41. Sullivan DA, Bloch KJ, Allansmith MR. Hormonal influence on the secretory immune system of the eye: androgen regulation of secretory component levels in rat tears. J Immunol 1984; 132:1130-1135.
42. Sullivan DA, Bloch KJ, Allansmith MR. Hormonal influence on the secretory immune system of the eye: androgen control of secretory component production by the rat exorbital gland. Immunology 1984; 52:239-246.
43. Winderickx J, Vercaeren I, Verhoeven G, Heyns W. Androgen-dependent expression of cystatin-related protein (CRP) in the exorbital lacrimal gland of the rat. J Steroid Biochem Molec Biol 1994; 48:165-170.
44. Sullivan DA, Allansmith MR. Hormonal influence on the secretory immune system of the eye: androgen modulation of IgA levels in tears of rats. J Immunol 1985; 134:2978-2982.
45. Calmettes L, Déodati F, Planel H, Bec P. Influence des hormones génitales sur la glande lacrymale. Bull Soc Franc Ophtal 1956; 69:263-270.
46. Gubits RM, Lynch KR, Kulkarni AB, Dolan KP, Gresik EW, Hollander P, et al. Differential regulation of a 2u globulin gene expression in liver, lachrymal gland, and salivary gland. J Biol Chem 1984; 259:12803-12809.
47. Obata H, Yamamoto S, Horiuchi H, Machinami R. Histopathologic study of the human lacrimal gland. Statistical analysis with special reference to aging. Ophthalmology 1995; 102:678-686.
48. Rocha FJ, Wickham LA, Pena JDO, Gao J, Ono M, Lambert RW, et al. Influence of gender and the endocrine environment on the distribution of androgen receptors in the lacrimal gland. J Steroid Biochem Molec Biol 1993; 46:737-749.
49. Huang Z, Gao J, Wickham LA, Sullivan, DA. Influence of gender and androgen treatment on TGF-b1 mRNA levels in the rat lacrimal gland. Invest Ophthalmol Vis Sci 1995; 35:S991.
50. Richards SM, Liu M, Sullivan BD, Sullivan DA. Gender-related differences in gene expression of the lacrimal gland. Adv Exp Med Biol 2002; 506:121-128.
51. Rocha EM, Sullivan BD, Toda I, Wickham, LA, Silveira LA, Sullivan DA. Sex and androgen effects on cytokine mRNA levels in lacrimal tissues of mouse models of Sjögren’s syndrome. In preparation, 2004.
52. Wickham LA, Rocha AM, Gao J, Krenzer KL, Silveira LA, Toda I, et al. Identification and hormonal control of sex steroid receptors in the eye. Adv Exp Med Biol 1998; 438:95-100.
53. Huang Z, Lambert RW, Wickham A, Sullivan DA. Analysis of cytomegalovirus infection and replication in acinar epithelial cells of the rat lacrimal gland. Invest Ophthalmol Vis Sci 1996; 37:1174-1186.
54. Bromberg BB, Welch MH, Beuerman RW, Chew S-J, Thompson HW, Ramage D, et al. Histochemical distribution of carbonic anhydrase in rat and rabbit lacrimal gland. Invest Ophthalmol Vis Sci 1993; 34:339-348.
55. De PK. Sex differences in content of peroxidase, a porphyrin containing enzyme, in hamster lacrimal gland. In: Abstracts of the International Conference on the Lacrimal Gland, Tear Film and Dry Eye Syndromes: Basic Science and Clinical Relevance, Bermuda, 1992:40.
56. Sashima M, Hatakeyama S, Satoh M, Suzuki A. Harderianization is another sexual dimorphism of rat exorbital lacrimal gland. Acta Anat 1989; 135:303-306.
57. Parhon CI, Babes A, Petrea I, Istrati F, Burgher E. Structura si Dimorfismul sexual al glandelor parotide la Sobolanul Alb. Bul Stiint Sect de Stünte Med 1955; 7:3.
58. Sullivan DA, Colby E, Hann LE, Allansmith MR, Wira CR. Production and utilization of a mouse monoclonal antibody to rat IgA: identification of genderrelated differences in the secretory immune system. Immunol Invest 1986; 15:311-318.
59. Sullivan DA, Block L, Pena JDO. Influence of androgens and pituitary hormones on the structural profile and secretory activity of the lacrimal gland. Acta Ophthalmol Scand 1996; 74:421-435.
60. Remington SG, Lima PH, Nelson JD. Pancreatic lipase mRNA isolated from female mouse. Invest Ophthalmol Vis Sci 1997; 38:S149.
61. Craig JP, Tomlinson A. Age and gender effects on the normal tear film. Adv Exp Med Biol 1998; 438:411-415.
62. Barton K, Nava A, Monroy DC, Pflugfelder SC. Cytokines and tear function in ocular surface disease. Adv Exp Med Biol 1998; 438:461-469.
63. van Setten G, Schultz G. Transforming growth factor-alpha is a constant component of human tear fluid. Graefe’s Arch Clin Exp Ophthalmol 1994; 232:523-526.
64. Bodelier VMW, van Haeringen NJ. Gender related differences in tear fluid protein profiles of mice. In: Abstracts of the IVth International Congress of the International Society of Dacryology, Stockholm, Sweden, 1996:24.
65. Fox RI, ed. Sjögren’s Syndrome. Rheum Dis Clin N Am 1992; vol 18.
66. Talal N, Moutsopoulos HM, Kassan SS, eds. Sjögren’s Syndrome. Clinical and Immunological Aspects. Berlin: Springer-Verlag, 1987.
67. Homma M, Sugai S, Tojo T, Miyasaka N, Akizuki M, eds. Sjögren’s Syndrome. State of the Art. Amsterdam: Kugler, 1994.
68. Chew CKS, Hykin PG, Janswijer C, Dikstein S, Tiffany JM, Bron AJ. The casual level of meibomian lipids in humans. Curr Eye Res 1993; 12:255-259.
69. Krenzer KL, Cermak JM, Tolls DB, Papas AS, Dana MR, Sullivan DA. Comparative signs and symptoms of dry eye in primary and secondary Sjögren’s syndrome and meibomian gland disease. Invest Ophthalmol Vis Sci 1990; 40:S2864.
70. Nabata H, Horiuchi H, Miyata K, Tsuru T, Machinami R. Histopathological study of the human meibomian glands. Invest Ophthalmol Vis Sci Suppl 1994; 35:1789.
71. Hykin PG, Bron AJ. Age-related morphological changes in lid margin and meibomian gland anatomy. Cornea 1992; 11:334-342.
72. Sullivan DA. Sex hormones and Sjögren’s syndrome. J Rheumatol 1997; 24(suppl 50):17-32.
73. Homo-Delarche F, Durant S. Hormones, neurotransmitters and neuropeptides as modulators of lymphocyte functions. In: Rola-Pleszczynski M, ed. Handbook of Immunopharmacology. London: Academic Press, 1994; 169-240.
74. Ahmed SA, Penhale WJ, Talal N. Sex hormones, immune responses and autoimmune diseases. Am J Pathol 1985; 121:531-551.
75. Homo-Delarche F, Fitzpatrick F, Christeff N, Nunez EA, Bach JF, Dardenne M. Sex steroids, glucocorticoids, stress and autoimmunity. J Steroid Biochem Molec Biol 1991; 40:619-637.
76. Ahmed SA, Talal N. Sex hormones and the immune system-part 2. Animal data. Bailliere’s Clin Rheum 1990; 4:13-31.
77. Olsen NJ, Kovacs WJ. Gonadal steroids and immunity. Endocr Rev 1996; 17:369-384.
78. Cutolo M, Sulli A, Seriolo B, Masi AT. Estrogens, the immune response and autoimmunity. Clin Exp Rheumatol 1995; 13:217-226.
79. Beeson PB. Age and sex associations of 40 autoimmune diseases. Am J Med 1994; 96:457-462.
80. Kanda N, Tsuchida T, Tamaki K. Estrogen enhancement of anti-double-stranded DNA antibody and immunoglobulin G production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Arthr Rheum 1999; 42:328-337.
81. Ahmed SA, Talal N. Importance of sex hormones in systemic lupus erythematosus. In: Wallace D, Hahn B, eds. Dubois’ Lupus Erythematosus. Philadelphia: Lea & Febiger, 1993; 148-156.
82. Bynoe MS, Grimaldi CM, Diamond B. Estrogen up-regulates Bcl-2 and blocks tolerance induction of naive B cells. Proc Natl Acad Sci USA 2000; 97:2703-2708.
83. Sakabe K, Yoshida T, Furuya H, Kayama F, Chan EK. Estrogenic xenobiotics increase expression of SS-A/Ro autoantigens in cultured human epidermal cells. Acta Dermatol Venereol 1998; 78:420-423.
84. Van Griensven M, Bergijk EC, Baelde JJ, De Heer E, Bruijn JA. Differential effects of sex hormones on autoantibody production and proteinuria in chronic graftversus-host disease-induced experimental lupus nephritis. Clin Exp Immunol 1997; 107:254-260.
85. Verthelyi D, Ahmed SA. 17b-Estradiol, but not 5a-dihydrotestosterone, augments antibodies to double-stranded deoxyribonucleic acid in nonautoimmune C57BL/6J mice. Endocrinology 1994; 135:2615-2622.
86. Kanda N, Tsuchida T, Tamaki K. Testosterone suppresses anti-DNA antibody production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Arthr Rheum 1997; 40:1703-1171.
87. Wilder RL. Neuroendocrine-immune system interactions and autoimmunity. Annu Rev Immunol 1995; 13:307-338.
88. Jansson L, Holmdahl R. Estrogen-mediated immunosuppression in autoimmune diseases. Inflamm Res 1998; 47:290-301.
89. Appelmans M. La Kerato-conjonctivite seche de Gougerot-Sjogren. Arch Ophtalmol 1948; 81:577-588.
90. Bizzarro A, Valentini G, Di Marinto G, Daponte A, De Bellis A, Iacono G. Influence of testosterone therapy on clinincal and immunological features of autoimmune diseases associated with Klinefelter’s syndrome. J Clin Endocrinol Metab 1987; 64:32-36.
91. Harbuz MS, Perveen-Gill Z, Lightman SL, Jessop DS. A protective role for testosterone in adjuvant-induced arthritis. Br J Rheumatol 1995; 34:1117-1122.
92. Brückner R. Uber einem erfolgreich mit perandren behandelten fall von Sjogren’schem symptomen komplex. Ophthalmologica 1945; 110:37-42.
93. Shoenfeld Y, Krause I, Blank M. New methods of treatment in an experimental murine model of systemic lupus erythematosus induced by idiotypic manipulation. Ann Rheum Dis 1997; 56:5-11.
94. Ahmed SA, Aufdemorte TB, Chen JR, Montoya AI, Olive D, Talal N. Estrogen induces the development of autoantibodies and promotes salivary gland lymphoid infiltrates in normal mice. J Autoimmun 1989; 2:543-552.
95. Carlsten H, Tarkowski A, Holmdahl R, Nilsson LA. Oestrogen is a potent disease accelerator in SLE-prone MRL lpr/lpr mice. Clin Exp Immunol 1990; 80:467-473.
96. Sato EH, Sullivan DA. Comparative influence of steroid hormones and immunosuppressive agents on autoimmune expression in lacrimal glands of a female mouse model of Sjögren’s syndrome. Invest Ophthalmol Vis Sci 1994; 35:2632-2642.
97. Grossman CJ. Are there underlying immune-neuroendocrine interactions responsible for immunological sexual dimorphism?. Prog Neurol Endocrinol Immun 1990; 3:75-82.
98. McMurray R, Keisler D, Kanuckel K, Izui S, Walker SE. Prolactin influences autoimmune disease activity in the female B/W mouse. J Immunol 1991; 147:3780-3787.
99. Reber PM. Prolactin and immunomodulation. Am J Med 1993; 95:637-644.
100. Elbourne KB, Keisler D, McMurray RW. Differential effects of estrogen and prolactin on autoimmune disease in the NZB/NZW F1 mouse model of systemic lupus erythematosus. Lupus 1998; 7:420-427.
101. Allen SH, Sharp GC, Wang G, Conley C, Takeda Y, Conroy SE, et al. Prolactin levels and antinuclear antibody profiles in women tested for connective tissue disease. Lupus 1996; 5:30-37.
102. Sato EH, Ariga H, Sullivan DA. Impact of androgen therapy in Sjögren’s syndrome: hormonal influence on lymphocyte populations and Ia expression in lacrimal glands of MRL/Mp-lpr/lpr mice. Invest Ophthalmol Vis Sci 1992; 33:2537-2545.
103. Ariga H, Edwards J, Sullivan DA. Androgen control of autoimmune expression in lacrimal glands of MRL/Mp-lpr/lpr mice. Clin Immunol Immunopathol 1989; 53:499-508.
104. Vendramini AC, Soo CH, Sullivan DA. Testosterone-induced suppression of autoimmune disease in lacrimal tissue of a mouse model (NZB/NZW F1) of Sjögren’s Syndrome. Invest Ophthalmol Vis Sci 1991; 32:3002-3006.
105. Rocha FJ, Sato EH, Sullivan BD, Sullivan DA. Effect of androgen analogue treatment and androgen withdrawal on lacrimal gland inflammation in a mouse model (MRL/Mp-lpr/lpr) of Sjögren’s syndrome. Reg Immunol 1994; 6:270-277.
106. Sullivan DA, Edwards J. Androgen stimulation of lacrimal gland function in mouse models of Sjögren’s syndrome. J Steroid Biochem Molec Biol 1997; 60:237-245.
107. Lahita RG. The connective tissue diseases and the overall influence of gender. Int J Fertil 1996; 41:156-165.
108. Lahita RG. The importance of estrogens in systemic lupus erythematosus. Clin Immunol Immunopathol 1992; 63:17-18.
109. Lahita RG, Bradlow HL, Ginzler E, Pang S, New M. Low plasma androgens in women with systemic lupus erythematosus. Arthr Rheum 1987; 30:241-248.
110. Lavalle C, Loyo E, Paniagua R, Bermudez JA, Herrera J, Graef A, et al. Correlation study between prolactin and androgens in male patients with systemic lupus erythematosus. J Rheum 1987; 14:268-272.
111. Xu G, Shang H, Zhu F. Measurement of serum testosterone level in female patients with dry eye. Proceedings of the International Congress of Ophthalmology Meeting (abstr); 1994.
112. Sullivan DA, Bélanger A, Cermak JM, Papas AS, Sullivan RM, Yamagami H, et al. Are women with Sjögren’s syndrome androgen deficient?. Invest Ophthalmol Vis Sci 2000; 41:S1453.
113. Redlich K, Ziegler S, Kiener HP, Spitzauer S, Stohlawetz P, Bernecker P, et al. Bone mineral density and biochemical parameters of bone metabolism in female patients with systemic lupus erythematosus. Ann Rheum Dis 2000; 59:308-310.
114. Valtysdóttir ST, Wide L, Hällgren. Low serum dehydroepiandrosterone sulfate in women with primary Sjögren’s syndrome as an isolated sign of impaired HPA axis function. J Rheumatol 2001; 28:1259-1265.
115. Jungers P, Khalil N, Pelissier C, Cougados M, Tron F, Bach J-F. Low plasma androgens in women with active or quiescent systemic lupus erythematosus. Arthr Rheum 1982; 25:454-457.
116. Derksen RH. Dehydroepiandrosterone (DHEA) and systemic lupus erythematosus. Semin Arthr Rheum 1998; 27:335-347.
117. Masi AT, Josipovic DB, Jefferson WE. Low adrenal androgenic-anabolic steroids in women with rheumatoid arthritis (rheumatoid arthritis): gas-liquid chromatographic studies of rheumatoid arthritis patients and matched normal control women indicating decreased 11-deoxy-17-ketosteroid excretion. Semin Arthr Rheum 1984; 14:1-23.
118. Cutolo M, Masi AT. Do androgens influence the pathophysiology of rheumatoid arthritis? Facts and hypotheses. J Rheumatol 1998; 25:1041-1047.
119. Cutolo M, Foppiani L, Prete C, Ballarino P, Sulli A, Villaggio B, et al. Hypothalamicpituitary-adrenocortical axis function in premenopausal women with rheumatoid arthritis not treated with glucocorticoids. J Rheumatol 1999; 26:282-288.
120. Masi AT, Bijlsma JW, Chikanza IC, Pitzalis C, Cutolo M. Neuroendocrine, immunologic, and microvascular systems interactions in rheumatoid arthritis: physiopathogenetic and therapeutic perspectives. Semin Arthr Rheum 1999; 29:65-81.
121. Fehér KG, Fehér T. Plasma dehydroepiandrosterone, dehydroepiandrosterone sulphate and androsterone sulphate levels and their interaction with plasma proteins in rheumatoid arthritis. Exp Clin Endocrinol 1984; 84:197-202.
122. Sambrook PN, Eisman JA, Champion GD, Pocock NA. Sex hormone status in postmenopausal women with rheumatoid arthritis. Arthr Rheum 1988; 31:973-978.
123. Cutolo M. Sex hormone adjuvant therapy in rheumatoid arthritis. Rheum Dis Clin N Am 2000; 26:881-895.
124. Lahita RG, Bradlow HL, Kunkel HG, Fishman J. Alterations of estrogen metabolism in systemic lupus erythematosus. Arthr Rheum 1979; 22:1195-1198.
125. Lahita RG, Bradlow HL, Kunkel HG, Fishman J. Increased 16a-hydroxylation of estradiol in systemic lupus erythematosus. J Clin Endocrinol Metab 1981; 53:174-178.
126. Rocha EM, Wickham LA, Huang Z, Toda I, Gao J, Silveira LA, et al. Presence and testosterone influence on the levels of anti- and pro-inflammatory cytokines in lacrimal tissues of a mouse model of Sjögren’s syndrome. Adv Exp Med Biol 1998; 438:485-491.
127. Robinson CP, Cornelius J, Bounous DE, Yamamoto H, Humphreys-Beher MG, Peck AB. Characterization of the changing lymphocyte populations and cytokine expression in the exocrine tissues of autoimmune NOD mice. Autoimmunity 1998; 27:29-44.
128. Zoukhri D, Kublin CL. Impaired neurotransmitter release from lacrimal and salivary gland nerves of a murine model of Sjogren’s syndrome. Invest Ophthalmol Vis Sci 2001; 42:925-932.
129. Takahashi M, Ishimaru N, Yanagi K, Haneji N, Saito I, Hayashi Y. High incidence of autoimmune dacryoadenitis in male non-obese diabetic (NOD) mice depending on sex steroid. Clin Exp Immunol 1997; 109:555-561.
130. Cauli A, Yanni G, Pitzalis C, Challacombe S, Panayi GS. Cytokine and adhesion molecule expression in the minor salivary glands of patients with Sjögren’s syndrome and chronic sialadenitis. Ann Rheum Dis 1995; 54:209-215.
131. Fox PC, Grisius MM, Sun D, Emmert-Buck M. Cytokines in saliva and salivary glands in primary Sjögren’s syndrome. J Rheumatol Suppl 1997; 50:38.
132. Elwaleed M, Zhu J, Deng G-M, Diab A, Link H, Klinge B, et al. Augmented levels of macrophage and Th1 cell-derived cytokine mRNA in MRL/lpr mice submandibular glands J Rheumatol Suppl 1997; 50:45.
133. Kolkowski E, Coll J, Roure-Mir C, Reth P, Bosch J, Pujol-Borrell, et al. Cytokine mRNA expression in minor salivary gland biopsies of primary Sjogren’s syndrome. J Rheumatol Suppl 1997; 50:45.
134. Hunger RE, Müller S, Laissue JA, Hess MW, Carnaud C, Garcia C, et al. Inhibition of submandibular and lacrimal gland infiltration in nonobese diabetic mice by transgenic expression of soluble TNF-receptor p55. J Clin Invest 1996; 98:954-961.
135. Nestler JE. Interleukin-1 stimulates the aromatase activity of human placental cytotrophoblasts. Endocrinology 1993; 132:566-570.
136. Purohit A, Ghilchik MW, Duncan L, Wang DY, Singh A, Walker MM, et al. Aromatase activity and interleukin-6 production by normal and malignant breast tissues. J Clin Endocrinol Metab 1995; 80:3052-3058.
137. Macdiarmid F, Wang D, Duncan LJ, Purohit A, Ghilchick MW, Reed MJ. Stimulation of aromatase activity in breast fibroblasts by tumor necrosis factor alpha. Molec Cell Endocrinol 1994; 106:17-21.
138. Speirs V, Adams EF, White MC. The anti-estrogen tamoxifen blocks the stimulatory effects of interleukin-6 on 17 beta-hydroxysteroid dehydrogenase activity in MCF-7 cells. J Steroid Biochem Molec Biol 1993; 46:605-611.
139. Sokoloff MH, Tso CL, Kaboo R, Taneja S, Pang S, deKernion JB, et al. In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines. Cancer 1996; 77:1862-1872.
140. Blais Y, Sugimoto K, Carriere MC, Haagensen DE, Labrie F, Simard J. Interleukin-6 inhibits the potent stimulatory action of androgens, glucocorticoids and interleukin-1 alpha on apolipoprotein D and GCDFP-15 expression in human breast cancer cells. Int J Cancer 1995; 62:732-737.
141. Kyprianou N, Isaacs JT. Activation of programmed cell death in the rat ventral prostate after castration. Endocrinology 1988; 122:552-562.
142. Norn MS. Desiccation of the precorneal tear film. I. Corneal wetting time. Acta Ophthalmol 1969; 47:865-880.
143. Luo F, Zhang H, Sun X. The change of tear secretion and tear film stability in castrated male rabbits. Chung Hua Yen Ko Tsa Chih 2001; 37:458-461.
144. Kao WWY, Wang IJ, Spaulding AG, J Funderburgh, CY Liu. Overexpression of biglycan induces ocular surface disorders in Ktcnpr-Bgln transgenic mice. Cornea 2000; 19(suppl 2):S98.
145. Yagyu H, Kitamine T, Osuga J, Tozawa R, Chen Z, et al. Absence of ACAT-1 attenuates atherosclerosis but causes dry eye and cutaneous xanthomatosis in mice with congenital hyperlipidemia. J Biol Chem 2000; 275:21324-32130.
146. Sullivan DA, Allansmith MR. Hormonal modulation of tear volume in the rat. Exp Eye Res 1986; 42:131-139.
147. Warren DW, Azzarolo AM, Huang ZM, Platler BW, Kaswan RL, Gentschein E, et al. Androgen support of lacrimal gland function in the female rabbit. Adv Exp Med Biol 1998; 438:89-93.
148. Sullivan DA, Sato EH. Immunology of the lacrimal gland. In: Albert DM, Jakobiec, FA, eds. Principles and Practice of Ophthalmology: Basic Sciences. Philadelphia: Saunders, 1994:479-486.
149. Aumüller G, Arce EA, Heyns W, Vercaeren I, Dammshäuser, Seitz J. Immunocytochemical localization of seminal proteins in salivary and lacrimal glands of the rat. Cell Tissue Res 1995; 280:171-181.
150. Dzierzykray-Rogalska I, Chodynicki S, Wisniewski L. The effect of gonadectomy on the parotid salivary gland and Loeventhal’s gland in white mice. Acta Med Polona 1963; 2:221-228.
151. Carriere R. The influence of the thyroid gland on polyploid cell formation in the external orbital gland of the rat. Am J Anat 1964; 115:1-16.
152. Cavallero C, Morera P. Effect of testosterone on the nuclear volume of exorbital lacrimal glands of the white rat. Experentia 1960; 16:285-286.
153. Myal Y, Iwasiow B, Yarmill A, Harrison E, Paterson JA, Shiu RP. Tissue-specific androgen-inhibited gene expression of a submaxillary gland protein, a rodent homolog of the human prolactin-inducible protein/GCDFP-15 gene. Endocrinology 1994; 135:1605-1610.
154. Winderickx J, Hemschoote K, De Clercq N, Van Dijck P, Peeters B, Rombauts W, et al. Tissue-specific expression and androgen regulation of different genes encoding rat prostatic 22-kilodalton glycoproteins homologous to human and rat cystatin. Molec Endocrinol 1990; 4:657-667.
155. Quintarelli G, Dellovo MC. Activation of glycoprotein biosynthesis by testosterone propionate on mouse exorbital glands. J Histochem Cytochem 1965; 13:361-364.
156. Vercaeren I, Winderickx J, Devos A, Peeters B, Heyns W. An effect of androgens on the length of the poly(A)-tail and alternative splicing cause size heterogeneity of the messenger ribonucleic acids encoding cystatin-related protein. Endocrinology 1992; 131:2496-2502.
157. Vanaken H, Claessens F, Vercaeren I, Heyns W, Peeters B, Rombauts W. Androgenic induction of cystatin-related protein and the C3 component of prostatic binding protein in primary cultures from the rat lacrimal gland. Molec Cell Endocrinol 1996; 121:197-205.
158. Krawczuk-Hermanowiczowa O. Effect of sex hormones on the lacrimal gland. III. Effects of testosterone and oestradiol and of both these hormones jointly on the morphological appearance of the lacrimal gland in castrated rats. Klin Oczna 1983; 85:337-339.
159. Radnót VM, Németh B. Wirkung der Testosteronpräparate auf die Tränendrüse. Ophthalmologica 1955; 129:376-380.
160. Radnot M, Nemeth B. Testosteronkészítmények hatása a könnymirigyre. Orvosi Hetilap 1954; 95:580-581.
161. Cavallero C, Offner P. Relative effectiveness of various steroids in an androgen assay using the exorbital lacrimal gland of the castrated rat. II. C19-steroids of the 5a-androstane series. Acta Endocrinol (Copenh) 1967; 55:131-135.
162. Cavallero C. The influence of various steroids on the Lowenthal lachrymal glands of the rat. Acta Endocrinol Suppl (Copenh) 1960; 51:861.
163. Cavallero C, Chiappino G, Milani F, Casella E. Uptake of 35S Labelled sulfate in the exorbital lacrymal glands of adult and newborn rats under different hormonal treatment. Experentia (Basel) 1960; 16:429
164. Nover A. The influence of testosterone and hypophysine on lacrimal secretion. Arzneim-Forsch 1957; 7:277-278.
165. Sullivan DA, Allansmith MR. Hormonal influence on the secretory immune system of the eye: endocrine interactions in the control of IgA and secretory component levels in tears of rats. Immunology 1987; 60:337-343.
166. Sullivan DA, Hann LE, Vaerman JP. Selectivity, specificity and kinetics of the androgen regulation of the ocular secretory immune system. Immunol Invest 1988; 17:183-194.
167. Azzarolo Am, Bjerrum K, Maves CA, Becker L, Wood RL, Mircheff AK, et al. Hypophysectomy-induced regression of female rat lacrimal glands: partial restoration and maintenance by dihydrotestosterone and prolactin. Invest Ophthalmol Vis Sci 1995; 36:216-226.
168. Claessens F, Vanaken H, Vercaeren I, Verrijdt G, Haelens A, Schoenmakers E, et al. Androgen-regulated transcription in the epithelium of the rat lacrimal gland. Adv Exp Med Biol 1998; 438:43-48.
169. Sullivan DA, Hann LE. Hormonal influence on the secretory immune system of the eye: endocrine impact on the lacrimal gland accumulation and secretion of IgA and IgG. J Steroid Biochem 1989; 34:253-262.
170. Ono M, Rocha FJ, Sullivan DA. Immunocytochemical location and hormonal control of androgen receptors in lacrimal tissues of the female MRL/Mp-lpr/lpr mouse model of Sjögren’s syndrome. Exp Eye Res 1995; 61:659-666.
171. Sullivan DA, Kelleher RS, Vaerman JP, Hann LE. Androgen regulation of secretory component synthesis by lacrimal gland acinar cells in vitro. J Immunol 1990; 145:4238-4244.
172. Hann LE, Kelleher RS, Sullivan D.A. Influence of culture conditions on the androgen control of secretory component production by acinar cells from the lacrimal gland. Invest Ophthalmol Vis Sci 1991; 32:2610-2621.
173. Kelleher RS, Hann LE, Edwards JA, Sullivan DA. Endocrine, neural and immune control of secretory component output by lacrimal gland acinar cells. J Immunol 1991; 146:3405-3412.
174. Lambert RW, Kelleher RS, Wickham LA, Vaerman JP, Sullivan DA. Neuroendocrinimmune modulation of secretory component production by rat lacrimal, salivary and intestinal epithelial cells. Invest Ophthalmol Vis Sci 1994; 35:1192-1201.
175. Wickham A, Huang Z, Lambert RW, Sullivan DA. Effect of sialodacryoadenitis virus exposure on acinar epithelial cells from the rat lacrimal gland. Ocular Immunol Immunopathol 1997; 5:181-195.
176. Vercaeren I, Vanaken H, Devos A, Peeters B, Verhoeven G, Heyns W. Androgens transcriptionally regulate the expression of cystatin-related protein and the C3 component of prostatic binding protein in rat ventral prostate and lacrimal gland. Endocrinology 1996; 137:4713-4720.
177. Sullivan DA, Wickham LA, Rocha EM, Kelleher RS, Silveira LA, Toda I. Influence of gender, sex steroid hormones and the hypothalamic-pituitary axis on the structure and function of the lacrimal gland. Adv Exp Med Biol 1998; 438:11-42.
178. Sullivan DA, Krenzer KL, Sullivan BD, Tolls BD, Toda I, Dana MR. Does androgen insufficiency cause lacrimal gland inflammation and aqueous tear deficiency?. Invest Ophthalmol Vis Sci 1999; 40:1261-1265.
179. Lagresa MNS, Suarez NM, Lescaille DV, Lagresa CMS. Inductores de lagrimas: androgenos y gammaglobulinas humanas. Rev Cubana Oftalmol 2000; 13:35-43.
180. Sullivan DA, Edwards JA, Wickham LA, Pena JDO, Gao J, Ono M, et al. Identification and endocrine control of sex steroid binding sites in the lacrimal gland. Curr Eye Res 1996; 15:279-291.
181. Clark JH, Schrader WT, O’Malley BW. Mechanisms of action of steroid hormones. In: Wilson JD, Foster DW, eds. Williams Textbook of Endocrinology. Philadelphia: Saunders, 1992.
182. McPhaul MJ, Young M. Complexities of androgen action. J Am Acad Dermatol 2001; 45:S87-S94.
183. Liu M, Richards SM, Schirra F, Sullivan DA. Sex and androgen influence on gene expression in lacrimal glands of normal and autoimmune mice. Assoc Res Vis Ophthalmol Ann Meeting 2002, abstr 3145.
184. Liu M, Richards SM, Schirra F, Sullivan DA. Androgen regulation of gene expression in the mouse lacrimal gland. Assoc Res Vis Ophthalmol Ann Meeting 2001, abstr.
185. Liu M, Richards SM, Schirra F, Yamagami H, Sullivan BD, Sullivan DA. Identification of androgen-regulated genes in the lacrimal gland. Adv Exp Med Biol 2002; 506:129-136.
186. Gurwood AS, Gurwood I, Gubman DT, Brzezick LJ. Idiosyncratic ocular symptoms associated with the estradiol transdermal estrogen replacement patch system. Optom Vis Sci 1995; 72:29-33.
187. Mircheff AK. Understanding the causes of lacrimal insufficiency: implications for treatment and prevention of dry eye syndrome. In: Research to Prevent Blindness Science Writers Seminar. New York: Research to Prevent Blindness, 1993:51-54.
188. Ruben M. Contact lenses and oral contraceptives. Br Med J 1966; 1:1110.
189. Jacobs M, Buxton D, Kramer P, Lubkin V, Dunn M, Herp A, et al. The effect of oophorectomy on the rabbit lacrimal system. Invest Ophthalmol Vis Sci Suppl 1986; 27:25.
190. Sator MO, Joura EA, Golaszewski T, Gruber D, Frigo P, Metka M, et al. Treatment of menopausal keratoconjunctivitis sicca with topical oestradiol. Br J Obstet Gynaecol 1998; 105:100-102.
191. Sorrentino C, Affinito P, Mattace Raso F, Loffredo M, Merlino P, Loffredo A, et al. Effetti della terapia ormonale sostitutiva sulla funzionalita oculare in postmenopausa. Minerva Ginecol 1998; 50:19-24.
192. Liberati V, de Feo G, Madia F, Marcozzi G. Effect of oral contraceptives on lacrimal fluid peroxidase activity in women. Ophthalm Res 2002; 34:251-253.
193. Huang SM, Azzarolo AM, Mircheff AK, Esrail R, Grayson G, Heller K, et al. Does estrogen directly affect lacrimal gland function. Invest Ophthalmol Vis Sci 1995; 36:S651.
194. Brennan NA, Efron N. Symptomatology of HEMA contact lens wear. Optom Vis Sci 1989; 66:834-838.
195. Medical Economics Data of Medical Economics Co, Inc. Physicians Desk Reference. Montvale, NJ, 1993:895-898.
196. Akramian J, Wedrich A, Nepp J, Sator M. Estrogen therapy in keratoconjunctivitis sicca. Adv Exp Med Biol 1998; 438:1005-1009.
197. Prijot E, Bazin L, Destexhe B. Essai de traitment hormonal de la keratoconjonctivite seche. Bull Soc Belge Ophtalmol 1972; 162:795-800.
198. Verbeck B. Augenbefunde und Stoffwechselverhalten bei Einnahme von Ovulationshemmern. Klin Mbl Augenheilk 1973; 162:612-621.
199. Laine M, Tenovuo J. Effect on peroxidase activity and specific binding of the hormone 17b-estradiol and rat salivary glands. Arch Oral Biol 1983; 8:847-852.
200. Valde G, Ghini M, Gammi L, Passarini M, Schiavi L. Effets des contraceptifs oraux triphases sur la secretion lacrymale. Ophtalmologie 1988; 2:129-130.
201. Lubkin V, Kramer P, Nash R, Bennett G. Evaluation of safety and efficacy of topical 17b-estradiol, 0.1% and 0.25%, in postmenopausal dry eye syndrome. In: Abstracts of the Second International Conference on the Lacrimal Gland, Tear Film and Dry Eye Syndromes: Basic Science and Clinical Relevance, Bermuda, 1996:160.
202. Ostachowicz M, Jettmar A, Laukienicki A. Próba leczenia zespolu Sjögrena hormonami plciowymi zenskimi. Wiad Lek 1973; 11:1075-1077.
203. Lubkin V, Nash R, Kramer P. The treatment of perimenopausal dry eye syndrome with topical estradiol. Invest Ophthalmol Vis Sci Suppl 1992; 33:1289.
204. Evans V, Millar TJ, Eden JA, Willcox MDP. Menopause, hormone replacement therapy and tear function. Adv Exp Med Biol 2002; 506:1029-1033.
205. Ishimaru N, Saegusa K, Yanagi K, Haneji N, Saito I, Hayashi Y. Estrogen deficiency accelerates autoimmune exocrinopathy in murine Sjogren’s syndrome through fas-mediated apoptosis. Am J Pathol 1999; 155:173-181.
206. Tekmal RR, Kirma N, Gill K, Fowler K. Aromatase overexpression and breast hyperplasia, an in vivo model-continued overexpression of aromatase is sufficient to maintain hyperplasia without circulating estrogens, and aromatase inhibitors abrogate these preneoplastic changes in mammary glands. Endocr Relat Cancer 1999; 6:307-314.
207. Schild G, Schauersberger J. About the effect of an estrogen-ointment on the ocular conjunctiva in postmenopausal women with keratoconjunctivitis sicca. Cornea 2000; 9(suppl 2):S121.
208. Azzarolo AM, Kaswan RL, Mircheff AK, Warren DW. Androgen prevention of lacrimal gland regression after ovariectomy of rabbits. Invest Ophthalmol Vis Sci Suppl 1994; 35:1793.
209. Coles N, Lubkin V, Kramer P, Weinstein B, Southren L, Vittek J. Hormonal analysis of tears, saliva, and serum from normals and postmenopausal dry eyes. Invest Ophthalmol Vis Sci Suppl 1988; 29:48.
210. Krasso I. Die behandlung der Erkrankungen des vorderen Bulbusabschnittes mit buckys Grenzstrahlen. Z Augenh 1930; 71:1-11.
211. Azzarolo AM, Mircheff AK, Kaswan R, Warren DW. Hypothesis for an indirect role of estrogens in maintaining lacrimal gland function. Invest Ophthalmol Vis Sci Suppl 1993; 34:1466.
212. Ubels JL, Wertz JT, Ingersoll KE, Jackson RS 2nd, Aupperlee MD. Down-regulation of androgen receptor expression and inhibition of lacrimal gland cell proliferation by retinoic acid. Exp Eye Res 2002; 75:561-571.
213. Suzuki T, Schaumberg DA, Sullivan BD, Liu M, Richards SM, Sullivan RM, et al. Do estrogen and progesterone play a role in the dry eye of Sjögren’s syndrome?. Ann NY Acad Sci 2002; 966:223-225.
214. Talal N. Natural history of murine lupus. Modulation by sex hormones. Arthr Rheum 1978; 21(5 suppl):S58-S63.
215. Roubinian JR, Talal N, Greenspan JS, Goodman JR, Siiteri PK. Effect of castration and sex hormone treatment on survival, anti-nucleic acid antibodies, and glomerulonephritis in NZB/NZW F1 mice. J Exp Med 1978; 147:1568-1583.
216. Nelson JL, Steinberg AD. Sex steroids, autoimmunity, and autoimmune diseases. In: Berczi I, Kovacs K, eds. Hormones and Immunity. Lancaster, England:MTP Press, 1987:93-119.
217. Apelgren LD, Bailey DL, Fouts RL, Short L, Bryan N, Evans GF, et al. The effect of a selective estrogen receptor modulator on the progression of spontaneous autoimmune disease in MRL lpr/lpr mice. Cell Immunol 1996; 173:55-63.
218. Haneji N, Nakamura T, Takio K, Yanagi K, Higashiyama H, Saito I, et al. Identification of a-fodrin as a candidate autoantigen in primary Sjögren’s syndrome. Science 1997; 276:604-607.
219. Grossman CJ. Regulation of the immune system by sex steroids. Endocr Rev 1984; 5:435-455.
220. Hattori M, Brandon MR. Thymus and the endocrine system: ovarian dysgenesis in neonatally thymectomized rats. J Endocrinol 1979; 83:101-111.
221. Verheul HA, Verveld M, Hoefakker S, Schuurs AH. Effects of ethinylestradiol on the course of spontaneous autoimmune disease in NZB/W and NOD mice. Immunopharmacol Immunotoxicol 1996; 17:163-180.
222. Keisler LW. Kier AB. Walker SE. Effects of prolonged administration of the 19-nor-testosterone derivatives norethindrone and norgestrel to female NZB/W mice: comparison with medroxyprogesterone and ethinyl estradiol. Autoimmunity 1991; 9:21-32.
223. Christ T, Marquardt R, Stodtmeister R, Pillunat LE. Zur Beeinflussung der Tränenfilmaufreibzeit durch hormonale Kontrazeptiva. Fortschr Ophthalmol 1986; 83:108-111.
224. Okon A, Jurowski P, Gos R. The influence of the hormonal replacement therapy on the amount and stability of the tear film among peri- and postmenopausal women. Klin Oczna 2001; 103:177-181.
225. Wenderlein M, Mattes S. The “dry eye” phenomenon and ovarian function. Study of 700 women pre- and postmenopausal. Zentralbl Gynakol 1996; 118:643-649.
226. Tomlinson A, Pearce EI, Simmons PA, Blades K. Effect of oral contraceptives on tear physiology. Ophthal Physiol Opt 2001; 21:9-16.
227. Sullivan DA, Tsubota K, Dartt DA, Stern ME, Sullivan RM, Bromberg BB, eds. Lacrimal Gland, Tear Film and Dry Eye Syndromes 3. Basic Science and Clinical Relevance. New York: Kluwer Academic/Plenum Press, 2002
228. Driver PJ, Lemp MA. Meibomian gland dysfunction. Surv Ophthalmol 1996; 40:343-367.
229. Tiffany JM. Physiological functions of the meibomian glands. Prog Retinal Eye Res 1995; 14:47-74.
230. Tiffany JM. Individual variations in human meibomian lipid composition. Exp Eye Res 1978; 27:289-300.
231. Tiffany JM. The lipid secretion of the meibomian glands. Adv Lipid Res 1987; 22:1-62.
232. McCulley JP, Shine W. A compositional based model for the tear film lipid layer. Trans Am Ophthalmol Soc 1997; 95:79-88.
233. Craig JP, Tomlinson A. Importance of the lipid layer in human tear film stability and evaporation. Optom Vis Sci 1997; 74:8-13.
234. Wickham LA, Gao J, Toda I, Rocha EM, Ono M, Sullivan DA. Identification of androgen, estrogen and progesterone receptor mRNAs in the eye. Acta Ophthalmol 2000; 78:146-153.
235. Rocha EM, Wickham LA, Silveira LA, Krenzer KL, Yu FS, Toda I, et al. Identification of androgen receptor protein and 5a-reductase mRNA in human ocular tissues. Br J Ophthalmol 2000; 84:76-84.
236. Schirra F, Suzuki T, Dickinson DP, Townsend DJ, Gipson IK, Sullivan DA. Identification of steroidogenic enzyme mRNAs in human ocular surface tissues and cells. Assoc Res Vis Ophthalmol Ann Meeting, 2003; abstr 1025.
237. Yamagami H, Schirra F, Liu M, Richards SM, Sullivan BD, Sullivan DA. Androgen influence on gene expression in the meibomian gland. Adv Exp Med Biol 2002; 506:477-482.
238. Steagall RJ, Yamagami H, Wickham LA, Sullivan DA. Androgen control of gene expression in the rabbit meibomian gland. Adv Exp Med Biol 2002; 506:465-476.
239. Schirra F, Suzuki T, Richards SM, Liu M, Sullivan DA. Androgen control of gene expression in the mouse meibomian gland. Submitted, 2004.
240. Schirra F, Richards SM, Liu M, Suzuki T, Yamagami H, Sullivan DA. Androgen regulation of lipogenic pathways in the mouse meibomian gland. Submitted, 2004.
241. Sullivan DA, Sullivan BD, Ullman MD, Rocha EM, Krenzer KL, Cermak JM, et al. Androgen influence on the meibomian gland. Invest Ophthalmol Vis Sci 2000; 41:3732-3742.
242. Krenzer KL, Dana MR, Ullman MD, Cermak JM, Tolls BD, Evans JE, et al. Effect of androgen deficiency on the human meibomian gland and ocular surface. J Clin Endocrinol Metab 2000; 85:4874-4882.
243. Sullivan BD, Evans JE, Krenzer KL, Dana MR, Sullivan DA. Impact of antiandrogen treatment on the fatty acid profile of neutral lipids in human meibomian gland secretions. J Clin Endocrinol Metab 2000; 85:4866-4873.
244. Sullivan BD, Evans JE, Dana MR, Sullivan DA. Impact of androgen deficiency on the lipid profiles in human meibomian gland secretions. Adv Exp Med Biol 2002; 506:449-458.
245. Cermak JM, Krenzer KL, Sullivan RM, Dana MR, Sullivan DA. Is complete androgen insensitivity syndrome associated with alterations in the meibomian gland and ocular surface?. Cornea 2003; 22:516-521.
246. Sullivan BD, Evans JE, Cermak JM, Krenzer KL, Dana MR, Sullivan DA. Complete androgen insensitivity syndrome: Effect on human meibomian gland secretions. Arch Ophthalmol 2002; 120:1689-1699.
247. Sullivan BD, Dana MR, Sullivan DA. Influence of aging on the polar and neutral lipid profiles in human mebiomian gland secretions. Invest Ophthalmol Vis Sci 2001; 42:S39.
248. Perra MT, Lantini MS, Serra A, Cossu M, De Martini G, Sirigu P. Human meibomian glands: a histochemical study for androgen metabolic enzymes. Invest Ophthalmol Vis Sci 1990; 31:771-775.
249. Zeligs MA, Gordon K. Dehydroepiandrosterone therapy for the treatment of dry eye disorders. Int Patent Application WO 94/04155, March 1994.
250. Connor CG. Treatment of dry eye with a transdermal 3% testosterone cream. Assoc Res Vis Ophthalmol Ann Meeting, 2003; abstr 2450.
251. Worda C, Nepp J, Huber JC, Sator MO. Treatment of keratoconjunctivitis sicca with topical androgen. Maturitas 2001; 37:209-212.
252. Connor CG, Primo EJ. A weak androgenic artificial tear solution decreases the osmolarity of dry eye patients. Invest Ophthalmol Vis Sci 2001; 42:S30.
253. Schaumberg DA, Buring JE, Sullivan DA, Dana MR. Hormone replacement therapy and the prevalence of dry eye syndrome. JAMA 2001; 286:2114-2119.
254. Wirth H, Gloor M, Kimmel W. Influence of cyproterone acetate and estradiol on cell kinetics in the sebaceous gland of the golden hamster ear. Arch Dermatol Res 1980; 268:277-281.
255. Thody AJ, Shuster S. Control and function of sebaceous glands. Physiol Rev 1989; 69:383-416.
256. Pochi PE, Strauss JS. Endocrinologic control of the development and activity of the human sebaceous gland. J Invest Dermatol 1974; 62:191-201.
257. Schafer G, Krause W. The effect of estradiol on the sebaceous gland of the hamster ear and its antagonism by tamoxifen. Arch Dermatol Res 1985; 277:230-234.
258. Sweeney TM, Szarnicki RJ, Strauss JS, Pochi PE. The effect of estrogen and androgen on the sebaceous gland turnover time. J Invest Dermatol 1969; 53:8-10.
259. Strauss JS, Kligman AM, Pochi PE. The effect of androgens and estrogens on human sebaceous glands. J Invest Dermatol 1962; 39:139-155.
260. Sansone-Bazzano G, Reisner RM, Bazzano G. A possible mechanism of action of estrogen at the cellular level in a model sebaceous gland. J Invest Dermatol 1972; 59:299-304.
261. Pochi PE. Acne: endocrinologic aspects. Cutis 1982; 30:212-222.
262. Saihan EM, Burton JL. Sebaceous gland suppression in female acne patients by combined glucocorticoid-oestrogen therapy. Br J Dermatol 1980; 103:139-142.
263. Pochi PE, Strauss JS. Sebaceous gland inhibition from combined glucocorticoidestrogen treatment. Arch Dermatol 1976; 112:1108-1109.
264. Kuscu NK, Toprak AB, Vatansever S, Koyuncu FM, Guler C. Tear function changes of postmenopausal women in response to hormone replacement therapy. Maturitas 2003; 44:63-68.
265. Suzuki T, Sullivan BD, Liu M, Schirra F, Richards SM, Yamagami H, et al. Estrogen and progesterone effects on the morphology of the mouse meibomian gland. Adv Exp Med Biol 2002; 506:483-488.
266. Esmaeli B, Harvey JT, Hewlett B. Immunohistochemical evidence for estrogen receptors in meibomian glands. Ophthalmology 2000; 107:180-184.
267. Sullivan BD, Evans JE, Sullivan RM, Schaumberg DA, Dana MR, Sullivan DA. Impact of hormone replacement therapy on the lipid profile of meibomian gland secretions in postmenopausal women. In preparation, 2004.